Chemistry:Valiltramiprosate
From HandWiki
Valiltramiprosate is an investigational new drug that is being evaluated to treat early Alzheimer's disease.[1] It is an amyloid precursor protein antagonist.[2] Phase III results published in late 2025 suggested valiltramiprosate offered some benefit to certain patients genetically predisposed to Alzheimers, primarily when the drug was taken before those paients had developed dementia.[3]
Valitramiprosate is being developed by drug maker Alzheon.
References
- ↑ "Valiltramiprosate - Alzheon". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800040203.
- ↑ "Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential". Expert Opinion on Pharmacotherapy 25 (7): 791–799. May 2024. doi:10.1080/14656566.2024.2360069. PMID 38814590.
- ↑ Hamilton, Jon (29 October 2025). "An Alzheimer's pill appears to protect some in a high-risk population". NPR. https://www.npr.org/sections/shots-health-news/2025/10/29/nx-s1-5575561/alzheimers-pill-apoe4-high-risk-lecanemab-donanemab.
 |  |
